Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Michael O'Connor
With
GE Healthcare
Age
18–90
Sex
FEMALE
Healthy volunteers
Not accepted
You may be eligible if
Have a lesion on mammogram, ultrasound or breast MRI that measured \< 15 mm in diameter, is considered suggestive or highly suggestive of malignancy according to the Breast Imaging Reporting and Data System Atlas criteria (BIRADS 4b, 4c or 5), and is scheduled for biopsy (needle biopsy and/or surgical biopsy).
OR
Have a lesion on mammogram, ultrasound or breast MRI that measured \> 15 mm in diameter, is known to be malignant and is scheduled for surgery.
Patient age \> 18 years of age.
Have a negative pregnancy test on the first day of the study, or must be postmenopausal or surgically sterilized.
You may not be if
Patients will be excluded if they have a small lesion (\< 15 mm) and have undergone prior needle biopsy of the lesion (such biopsy may effectively remove all or part of the lesion and angiogenesis associated with wound healing might confound imaging results with 99mTc-NC100692).
Patient's pregnancy is not negative on the first day of the study, or the patient is unable to complete the pregnancy test
Patient is unable to sit on a chair for 40 minutes
Clareo Health | Detection of Aggressive Breast Tumors Using Tc-99m-NC100692
